KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.

Increased expression of Notch signaling pathway components is observed in Kaposi sarcoma (KS) but the mechanism underlying the manipulation of the canonical Notch pathway by the causative agent of KS, Kaposi sarcoma herpesvirus (KSHV), has not been fully elucidated. Here, we describe the mechanism t...

Full description

Saved in:
Bibliographic Details
Main Authors: Victoria Emuss, Dimitrios Lagos, Arnold Pizzey, Fiona Gratrix, Stephen R Henderson, Chris Boshoff
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2009-10-01
Series:PLoS Pathogens
Online Access:https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1000616&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849468037459083264
author Victoria Emuss
Dimitrios Lagos
Arnold Pizzey
Fiona Gratrix
Stephen R Henderson
Chris Boshoff
author_facet Victoria Emuss
Dimitrios Lagos
Arnold Pizzey
Fiona Gratrix
Stephen R Henderson
Chris Boshoff
author_sort Victoria Emuss
collection DOAJ
description Increased expression of Notch signaling pathway components is observed in Kaposi sarcoma (KS) but the mechanism underlying the manipulation of the canonical Notch pathway by the causative agent of KS, Kaposi sarcoma herpesvirus (KSHV), has not been fully elucidated. Here, we describe the mechanism through which KSHV directly modulates the expression of the Notch ligands JAG1 and DLL4 in lymphatic endothelial cells. Expression of KSHV-encoded vFLIP induces JAG1 through an NFkappaB-dependent mechanism, while vGPCR upregulates DLL4 through a mechanism dependent on ERK. Both vFLIP and vGPCR instigate functional Notch signalling through NOTCH4. Gene expression profiling showed that JAG1- or DLL4-stimulated signaling results in the suppression of genes associated with the cell cycle in adjacent lymphatic endothelial cells, indicating a role for Notch signaling in inducing cellular quiescence in these cells. Upregulation of JAG1 and DLL4 by KSHV could therefore alter the expression of cell cycle components in neighbouring uninfected cells during latent and lytic phases of viral infection, influencing cellular quiescence and plasticity. In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.
format Article
id doaj-art-c0c852d5360c4fc39ab192ad09a59dca
institution Kabale University
issn 1553-7366
1553-7374
language English
publishDate 2009-10-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS Pathogens
spelling doaj-art-c0c852d5360c4fc39ab192ad09a59dca2025-08-20T03:25:58ZengPublic Library of Science (PLoS)PLoS Pathogens1553-73661553-73742009-10-01510e100061610.1371/journal.ppat.1000616KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.Victoria EmussDimitrios LagosArnold PizzeyFiona GratrixStephen R HendersonChris BoshoffIncreased expression of Notch signaling pathway components is observed in Kaposi sarcoma (KS) but the mechanism underlying the manipulation of the canonical Notch pathway by the causative agent of KS, Kaposi sarcoma herpesvirus (KSHV), has not been fully elucidated. Here, we describe the mechanism through which KSHV directly modulates the expression of the Notch ligands JAG1 and DLL4 in lymphatic endothelial cells. Expression of KSHV-encoded vFLIP induces JAG1 through an NFkappaB-dependent mechanism, while vGPCR upregulates DLL4 through a mechanism dependent on ERK. Both vFLIP and vGPCR instigate functional Notch signalling through NOTCH4. Gene expression profiling showed that JAG1- or DLL4-stimulated signaling results in the suppression of genes associated with the cell cycle in adjacent lymphatic endothelial cells, indicating a role for Notch signaling in inducing cellular quiescence in these cells. Upregulation of JAG1 and DLL4 by KSHV could therefore alter the expression of cell cycle components in neighbouring uninfected cells during latent and lytic phases of viral infection, influencing cellular quiescence and plasticity. In addition, differences in signaling potency between these ligands suggest a possible complementary role for JAG1 and DLL4 in the context of KS.https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1000616&type=printable
spellingShingle Victoria Emuss
Dimitrios Lagos
Arnold Pizzey
Fiona Gratrix
Stephen R Henderson
Chris Boshoff
KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
PLoS Pathogens
title KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
title_full KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
title_fullStr KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
title_full_unstemmed KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
title_short KSHV manipulates Notch signaling by DLL4 and JAG1 to alter cell cycle genes in lymphatic endothelia.
title_sort kshv manipulates notch signaling by dll4 and jag1 to alter cell cycle genes in lymphatic endothelia
url https://journals.plos.org/plospathogens/article/file?id=10.1371/journal.ppat.1000616&type=printable
work_keys_str_mv AT victoriaemuss kshvmanipulatesnotchsignalingbydll4andjag1toaltercellcyclegenesinlymphaticendothelia
AT dimitrioslagos kshvmanipulatesnotchsignalingbydll4andjag1toaltercellcyclegenesinlymphaticendothelia
AT arnoldpizzey kshvmanipulatesnotchsignalingbydll4andjag1toaltercellcyclegenesinlymphaticendothelia
AT fionagratrix kshvmanipulatesnotchsignalingbydll4andjag1toaltercellcyclegenesinlymphaticendothelia
AT stephenrhenderson kshvmanipulatesnotchsignalingbydll4andjag1toaltercellcyclegenesinlymphaticendothelia
AT chrisboshoff kshvmanipulatesnotchsignalingbydll4andjag1toaltercellcyclegenesinlymphaticendothelia